{"id":"NCT01486927","sponsor":"CSL Behring","briefTitle":"An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A","officialTitle":"A Phase I/III Open-label, Multicenter, Crossover Safety, Efficacy and Pharmacokinetic Study of Recombinant Coagulation Factor VIII (rFVIII) Compared to Recombinant Human Antihaemophilic Factor VIII (rFVIII; INN: Octocog Alfa) in Subjects With Hemophilia A, and a Repeat PK, Safety and Efficacy Study","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2012-02","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2011-12-07","resultsPosted":"2016-08-09","lastUpdate":"2016-08-09"},"enrollment":175,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hemophilia A"],"interventions":[{"type":"BIOLOGICAL","name":"rVIII-SingleChain","otherNames":["Recombinant Factor VIII (rFVIII)","CSL627"]},{"type":"BIOLOGICAL","name":"Octocog alfa","otherNames":["Human coagulation factor VIII (rDNA)"]}],"arms":[{"label":"Recombinant Factor VIII (rFVIII)","type":"EXPERIMENTAL"}],"summary":"This is an open-label, non-randomized, efficacy, safety and pharmacokinetic (PK) study comparing octocog alfa and rVIII-SingleChain. The study consists of three parts, a PK period (Part 1), a continuation of dosing safety and efficacy period (Part 2) and a safety, efficacy, and repeat PK period (Part 3) and also includes a surgical sub-study for subjects enrolled in Parts 2 and 3.","primaryOutcome":{"measure":"Treatment Success","timeFrame":"Up to 24 months","effectByArm":[{"arm":"rVIII-SingleChain On-demand","deltaMin":92.4,"sd":null},{"arm":"rVIII-SingleChain Prophylaxis","deltaMin":92.2,"sd":null},{"arm":"rVIII-SingleChain","deltaMin":92.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":56,"countries":["United States","Australia","Austria","Canada","Czechia","Germany","Hungary","Italy","Japan","Lebanon","Malaysia","Netherlands","Philippines","Poland","Romania","Russia","South Africa","Spain","Ukraine","United Kingdom"]},"refs":{"pmids":["27330001"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":174},"commonTop":["Arthralgia","Nasopharyngitis","Headache"]}}